Approaches to organ-preserving treatment of uterine fibroids began to develop in parallel with the creation of radical methods of treating this disease, but this direction has always lagged somewhat behind and had few supporters. Recently, organ-preserving treatment of uterine fibroids has become one of the priority areas. In general, this is a completely natural process, due to both the development of modern treatment technologies and the growing need of women to solve reproductive problems. What is the reason for this? On the one hand, there is a persistent tendency to get pregnant at a late reproductive age, on the other hand, uterine fibroids are increasingly diagnosed in young, nulliparous women. In addition, the development of the media and the Internet is of no small importance, which, in turn, began to pay more attention to health and medical issues, covering new medical technologies.

Effective organ-preserving treatment of uterine fibroids is impossible without a full understanding of this disease. The concept of "uterine fibroids" includes a heterogeneous group of conditions that characterize pathological changes in the uterus. The doctor can call uterine fibroids a single node in the uterus 1 cm in size, which does not have any clinical manifestation, and multiple uterine fibroids, corresponding to 25 weeks of pregnancy, manifested by bleeding and compression of adjacent organs. Therefore, the approach to the treatment of this disease largely depends on the correct clinical classification. The currently existing classifications (histological and localization) are unacceptable in practical gynecology and in fact do not carry any tactical information. The currently widely used indications for hysterectomy in practice make it possible to observe patients up to the turn of 12 weeks, i.e., they allow passivity in relation to patients with smaller fibroids. Thus, a classification is needed that combines such characteristics as: size, number of nodes, localization, and reproductive plans of the patient, that is, a classification is needed that allows the doctor to predict treatment tactics immediately.

Uterine fibroids, mifepristone, uterine artery embolization

Крайнюков П. Е. и др. Эмболизация маточных артерий-перспективы лечения пациенток с фибромиомой матки //Главный врач Юга России. – 2011. – №. 3 (26). – С. 44-47.

Мусинжанова П. С. и др. ЗНАЧЕНИЕ ВОСПАЛИТЕЛЬНЫХ ПРОЦЕССОВ ГЕНИТАЛИЙ В ПРОИСХОЖДЕНИИ ЖЕНСКОГО БЕСПЛОДИЯ (ОБЗОР ЛИТЕРАТУРЫ) //International scientific review of the problems of natural sciences and medicine. – 2019. – С. 136-149.

Оразов М. Р. и др. Аденомиоз как причина бесплодия: реальная или мнимая связь? //Акушерство и гинекология: Новости. Мнения. Обучения. – 2023. – Т. 11. – №. S. – С. 132-138.

Плисова Е. С. РАЗВИТИЕ РОБОТОВ В ХИРУРГИИ //АКТУАЛЬНЫЕ ПРОБЛЕМЫ ТЕХНИЧЕСКИХ НАУК В РОССИИ И. – 2016. – С. 139.

Татарчук Т. Ф., Косей Н. В. Современные принципы лечения лейомиомы матки //Здоров’я України.–2012.–Тематичний номер. – 2012. – С. 10-13.

Хасанова Д. НАРУШЕНИЕ МОЧЕИСПУСКАНИЯ У БЕРЕМЕННЫХ //Евразийский журнал медицинских и естественных наук. – 2023. – Т. 3. – №. 10. – С. 90-94.

Хасанова Д., Камалова Д. Диагностика аутоиммунного тиреоидита у беременных и изучение исходов родов //Журнал биомедицины и практики. – 2021. – Т. 1. – №. 3/2. – С. 14-18.

Шопулотова З. А., Худоярова Д. Р. ХРОНИЧЕСКИЙ ПИЕЛОНЕФРИТ И БЕРЕМЕННОСТЬ: ВЛИЯНИЕ КОМОРБИДНОСТИ И ЕГО ПРОЯВЛЕНИЯ //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2023. – Т. 4. – №. 4.

Angioni S., D'Alterio M. N., Daniilidis A. Highlights on medical treatment of uterine fibroids //Current Pharmaceutical Design. – 2021. – Т. 27. – №. 36. – С. 3821-3832.

Abdukhamidovna K. D. A DIFFERENTIATED APPROACH TO THE TREATMENT OF INFERTILITY IN PCOS //American Journal Of Biomedical Science & Pharmaceutical Innovation. – 2023. – Т. 3. – №. 04. – С. 1-6.

Abdukhamidovna K. D. MANAGEMENT OF PREGNANT WOMEN WITH IDIOPATIC THROMBOCYTOPENIC PURPLE //European International Journal of Multidisciplinary Research and Management Studies. – 2023. – Т. 3. – №. 02. – С. 16-21.

Boosz A. S. et al. The conservative and interventional treatment of fibroids //Deutsches Ärzteblatt International. – 2014. – Т. 111. – №. 51-52. – С. 877.

De La Cruz M. S. D., Buchanan E. M. Uterine fibroids: diagnosis and treatment //American family physician. – 2017. – Т. 95. – №. 2. – С. 100-107.

Dilafruz A. The Practice-oriented approach to learning in europe //Conferencea. – 2023. – С. 79-80

Hasanova D. The governor is a woman who lives with the pain of the people //Texas Journal of Multidisciplinary Studies. – 2021. – Т. 3. – С. 57-58.

Shopulotova Z. A., Zubaydilloeva Z. K. THE VALUE OF ULTRASOUND DIAGNOSTICS IN PREGNANT WOMEN WITH CHRONIC PYELONEPHRITIS //Бюллетень студентов нового Узбекистана. – 2023. – Т. 1. – №. 9. – С. 19-22.

Shopulotova Z. COMPARATIVE ANALYSIS OF CLINICAL CASES OF EXACERBATION OF CHRONIC PYELONEPHRITIS IN PREGNANT WOMEN //International Bulletin of Medical Sciences and Clinical Research. – 2023. – Т. 3. – №. 8. – С. 22-25.

Shopulotova Z. A., Zubaydilloeva Z. K., Khudoyarova D. R. COMORBID EVENTS IN PREGNANT WOMEN WITH PYELONEPHRITIS AND PREVENTION OF THESE CONDITIONS //Бюллетень педагогов нового Узбекистана. – 2023. – Т. 1. – №. 9. – С. 35-38.

Shopulotova Z. A., Zubaydilloeva Z. K. THE VALUE OF ULTRASOUND DIAGNOSTICS IN PREGNANT WOMEN WITH CHRONIC PYELONEPHRITIS //Бюллетень студентов нового Узбекистана. – 2023. – Т. 1. – №. 9. – С. 19-22.

Shopulotova Z. A. et al. PHENOMENA OF COMORBIDITY IN PREGNANT WOMEN WITH PYELONEPHRITIS.